“骗保”风波下的爱尔医疗投资：隐秘持股15家精神病院，旗下上市公司屡罚屡犯

Core Viewpoint - The controversy surrounding the alleged fraudulent activities of mental health hospitals in Hubei has implicated Chen Bang, the actual controller of Aier Eye Hospital, raising concerns about the company's governance and compliance practices [3][11][18]. Group 1: Company Structure and Ownership - Aier Eye Hospital has distanced itself from the implicated Xiangyang Hengtai Kang Hospital, stating that it is not part of the listed company's consolidated financial statements and is a fourth-level subsidiary established by Aier Medical Investment Group and other social capital [3][8][23]. - Aier Medical Investment Group, the largest shareholder of Aier Eye Hospital with a 34.34% stake, indirectly holds shares in 15 other mental health rehabilitation hospitals, with ownership percentages ranging from 10% to 70%, all ultimately benefiting Chen Bang [3][19][23]. - The management team of Hunan Hengtai Kang, the direct shareholder of Xiangyang Hengtai Kang Hospital, has overlaps with Aier Medical Investment, indicating potential governance issues [4][19][24]. Group 2: Compliance Issues and Penalties - Aier Eye Hospital and its subsidiaries have faced multiple penalties for fraudulent activities related to medical insurance claims, including a notable case in September 2022 where a subsidiary was fined for various violations, including overcharging and improper billing practices [11][26][29]. - The company has also been criticized for allegedly using charitable activities as a means to manipulate insurance reimbursements, raising ethical concerns about its operational practices [12][27]. - Frequent violations have not only damaged Aier Eye Hospital's brand reputation but have also led to a noticeable slowdown in its financial performance, with revenue growth declining significantly in recent years [14][29][30]. Group 3: Financial Performance and Market Concerns - Aier Eye Hospital's revenue for 2024 is reported at 20.983 billion, with a net profit of 3.556 billion, reflecting a revenue growth rate of only 3.02% and a net profit growth rate of 5.87% [14][29]. - The downward trend in profitability is further highlighted by the 2025 data, where the first three quarters show a revenue of 17.484 billion, a year-on-year increase of 7.25%, but a net profit decline of 9.76% to 3.115 billion [14][29][30]. - Concerns about the company's financial stability have been exacerbated by Chen Bang's pledge of 620 million shares for financing, raising alarms about the company's cash flow and funding situation [15][30].